ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
about
Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience.Correction: ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13.Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration.GAG and collagen II attenuate glucocorticoid-induced osteoporosis by regulating NF-κB and MAPK signaling.
P2860
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@ast
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@en
type
label
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@ast
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@en
prefLabel
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@ast
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@en
P2093
P2860
P50
P1433
P1476
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
@en
P2093
Camilo Toro
Cornelius F Boerkoel
Gexin Zhao
Haigen Huang
John Accardi
Kevin Bishop
May Christine V Malicdan
Tadafumi Yokoyama
Valerie Maduro
P2860
P304
P356
10.1371/JOURNAL.PGEN.1006481
P577
2017-02-03T00:00:00Z